CompoAtlas

Oméga-3 AEP/ADH

Natural health product licensed in Canada

Other names
Omega-3 EPA/DHA
Licence holder
9231-6124 Québec Inc.
NPN or DIN-HM
80053331
Status
Active licence
Licence date
22 August 2014
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Huile de poisson

Source : Engraulidae - en entier

Potency : 180 mg Acide éicosapentaéoïque

300 mgNot calculated
Huile de poisson

Source : Scombridae - en entier

Potency : 180 mg Acide éicosapentaéoïque

300 mgNot calculated
Huile de poisson

Source : Clupeidae - en entier

Potency : 180 mg Acide éicosapentaéoïque

300 mgNot calculated
Huile de poisson

Source : Engraulidae - en entier

Potency : 120 mg Acide docosahexaénoïque

Not specifiedNot calculated
Huile de poisson

Source : Scombridae - en entier

Potency : 120 mg Acide docosahexaénoïque

Not specifiedNot calculated
Huile de poisson

Source : Clupeidae - en entier

Potency : 120 mg Acide docosahexaénoïque

Not specifiedNot calculated

Non-medicinal ingredients

Gélatine, Glycérine, Vitamine E, Saveur d'agrumes, Eau purifiée

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 Capsule ; maximum: 4 Capsuleminimum: 1 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Source d'acides gras oméga-3 pour le maintien d'une bonne santé. Source d'acide éicosapentaénoïque (AEP) et d'acide docosahexanïque (ADH) pour le maintien d'une bonne santé. Aide à contribuer à la santé cognitive et/ou aux fonctions cérébrales. Aide à contribuer au développement du cerveau, des yeux et des refs chez les enfants âgés de 12 ans et moins. Aide au maintien de la santé cardiovasculaire. Aide à réduire le taux de triglycérols sanguins.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80053331

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line